Clinical practice guideline for dedicated breast PET
详细信息 查看全文
- 作者：Makoto Hosono (1) (2)
Tsuneo Saga (2)
Kengo Ito (2)
Shinichiro Kumita (2)
Masayuki Sasaki (2)
Michio Senda (2)
Jun Hatazawa (2)
Hiroshi Watanabe (2)
Hiroshi Ito (2)
Shinichi Kanaya (2)
Yuichi Kimura (2)
Hideo Saji (2)
Seishi Jinnouchi (2)
Hiroyoshi Fukukita (2)
Koji Murakami (2)
Seigo Kinuya (3)
Junichi Yamazaki (3)
Mayuki Uchiyama (3)
Koichi Uno (3)
Katsuhiko Kato (3)
Tsuyoshi Kawano (3)
Kazuo Kubota (3)
Takashi Togawa (3)
Norinari Honda (3)
Hirotaka Maruno (3)
Mana Yoshimura (3)
Masami Kawamoto (4)
Yukihiko Ozawa (4) - 刊名：Annals of Nuclear Medicine
- 出版年：2014
- 出版时间：July 2014
- 年：2014
- 卷：28
- 期：6
- 页码：597-602
- 全文大小：164 KB
- 参考文献：1. FDG-PET, PET/CT Diagnostic Guideline 2012 (Japanese Society of Nuclear Medicine). Kaku Igaku (Jpn. J. Nucl. Med.) 2012;49(4):39鈥?0.
2. Ichizawa N, et al. Long-term results of T1a, T1b and T1c Invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification. Jpn J Clin Oncol. 2002;32(3):108鈥?. CrossRef
3. Schilling K, et al. The role of positron emission mammography in breast cancer imaging and management. Appl Radiol. 2008;37(4):26鈥?6.
4. Berg WA, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression (鈥減ositron emission mammography鈥? is highly accurate in depicting primary breast cancer. Breast J. 2006;12(4):309鈥?3. CrossRef
5. Berg WA, et al. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology. 2011;258(1):59鈥?2. CrossRef
6. Schilling K, et al. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2011;38(1):23鈥?6. CrossRef
7. Furuta M, et al. Basic evaluation of a C-shaped breast PET scanner. IEEE NSS&MIC 2009 Conference Record 2548鈥?552.
8. Iima M, et al. Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation. J Nucl Med. 2012;53(10):1534鈥?2. CrossRef
9. Guideline for performing PET scans using FDG manufactured in the hospital (Vol. 2) (Japanese Society of Nuclear Medicine) Kaku Igaku (Jpn. J. Nucl. Med.) 2005;42(4):1鈥?2.
10. Guideline for imaging techniques in FDG-PET scans (Japanese Society of Nuclear Medicine) The Japanese Journal of Nuclear Medicine Technology 2007;27:425鈥?56.
11. Narayanan D, et al. Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility. AJR Am J Roentgenol. 2011;196(4):971鈥?1. CrossRef
12. ICRP Publication 106. Ann ICRP 2008;38.
13. Wahl RL, et al. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol. 1993;11(11):2101鈥?1.
14. Smith IC, et al. Positron emission tomography using [(18)F]-fluorodeoxy-d -glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol. 2000;18(8):1676鈥?8.
15. Rousseau C, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol. 2006;24(34):3566鈥?2. CrossRef
16. ACR Practice Guideline for the Performance of Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast. Breast Imaging and Intervention. 10 http://www.acr.org/Quality-Safety/Standards-Guidelines/Practice-Guidelines-by-Modality/media/ACR/Documents/PGTS/guidelines/MRI_Breast/pdf. Resolution 25. 2008.
17. Mann RM, et al. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008;18:1307鈥?8. CrossRef
18. Sugano K, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Cancer Sci. 2008;99:1967鈥?6. CrossRef
19. Saslow E, et al. American Cancer Society Guidelines for breast screening with MRI as an adjunct to mammography. Cancer J Clin. 2007;57:75鈥?9. CrossRef
20. Wang CL, et al. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG. AJR Am J Roentgenol. 2011;197(2):247鈥?5. CrossRef
21. Guideline for breast MRI screening in breast cancer high-risk groups, ver.1.0 Japan Association of Breast Cancer Screening, MRI Screening Committee).
22. FDG-PET, PET/CT practice聽guideline 2012 (Japanese Society of Nuclear Medicine), Kaku Igaku (Jpn. J. Nucl. Med.) 2012; 49(4):391鈥?01. - 作者单位：Makoto Hosono (1) (2)
Tsuneo Saga (2)
Kengo Ito (2)
Shinichiro Kumita (2)
Masayuki Sasaki (2)
Michio Senda (2)
Jun Hatazawa (2)
Hiroshi Watanabe (2)
Hiroshi Ito (2)
Shinichi Kanaya (2)
Yuichi Kimura (2)
Hideo Saji (2)
Seishi Jinnouchi (2)
Hiroyoshi Fukukita (2)
Koji Murakami (2)
Seigo Kinuya (3)
Junichi Yamazaki (3)
Mayuki Uchiyama (3)
Koichi Uno (3)
Katsuhiko Kato (3)
Tsuyoshi Kawano (3)
Kazuo Kubota (3)
Takashi Togawa (3)
Norinari Honda (3)
Hirotaka Maruno (3)
Mana Yoshimura (3)
Masami Kawamoto (4)
Yukihiko Ozawa (4)
1. Institute of Advanced Clinical Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, 589-8511, Osaka, Japan
2. PET Nuclear Medicine Committee, Japanese Society of Nuclear Medicine, Tokyo, Japan
3. Health Insurance Committee, Japanese Society of Nuclear Medicine, Tokyo, Japan
4. Japanese Society of Nuclear Medicine, Tokyo, Japan - ISSN：1864-6433
文摘